ASP8062: Clinical Trials

3 trials of ASP8062, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 withdrawn. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Withdrawn 1

Follow ASP8062: new trials by email Literature Review of ASP8062 trials Research Report on ASP8062

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Human Laboratory Study of ASP8062 for Alcohol Use Disorder
ASP8062, Placebo - Alcohol Use Disorder, Alcohol Drinking
Phase 2CompletedNational Institute on Alcohol Abuse and Alcoholism (NIAAA)602021-12-132024-12-03
A Study to Assess the Safety and Efficacy of ASP8062 as an Add-on Therapy to Buprenorphine/Naloxone in Participants With Opioid Use Disorder
ASP8062, Placebo ASP8062, buprenorphine/naloxone - Opioid Use Disorder
Phase 2WithdrawnAstellas Pharma Global Development, Inc.2021-11-082024-11-06
A Study to Assess the Analgesic Efficacy and Safety of ASP8062 in Subjects With Fibromyalgia
ASP8062, Placebo - Fibromyalgia
Phase 2CompletedAstellas Pharma Global Development, Inc.1832017-05-082025-11-03

Conditions studied

Alcohol Drinking (1)  ·  Alcoholism (1)  ·  Fibromyalgia (1)  ·  Opioid-Related Disorders (1)

Sponsors

Astellas Pharma Global Development, Inc. (2)  ·  National Institute on Alcohol Abuse and Alcoholism (NIAAA) (1)

Countries

United States (2)

Top investigators

Raye Litten, Ph.D. (1)